Imed Infinity Medical-Limited Partnership (IMED.TA)
ILA 99.8
(0.0%)
ILA 99.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | -942 Thousand | 200 Thousand | 75 Thousand | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | -942 Thousand | 200 Thousand | 75 Thousand | - |
| Operating Expenses | 791 Thousand | 815 Thousand | 968 Thousand | 136 Thousand |
| Selling, General and Administrative Expenses | 791 Thousand | 815 Thousand | 968 Thousand | 136 Thousand |
| Research and Development Expenses | 16 Million | 10.6 Million | 10.2 Million | - |
| Other Expenses | -16 Million | - | - | - |
| Cost and Expenses | 791 Thousand | 815 Thousand | 968 Thousand | 136 Thousand |
| Operating Income | -1.73 Million | -615 Thousand | -893 Thousand | -136 Thousand |
| Interest Expense | - | - | - | - |
| Income Tax Expense | - | -1.37 Million | 394.11 Thousand | - |
| Earnings before Tax | -1.77 Million | -1 Million | -766 Thousand | -136 Thousand |
| Net Income | -1.77 Million | -1 Million | -766 Thousand | -136 Thousand |
| Earnings Per Share Basic | -0.44 | -0.25 | -0.19 | - |
| Earnings Per Share Diluted | -0.44 | -0.25 | -0.19 | - |
| Weighted Average Shares Outstanding | 4.02 Million | 4.02 Million | 4.03 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 4.02 Million | 4.02 Million | 4.03 Million | - |
| Gross Margin | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | - | -1.96 | 1.69 | - |
| Profit Margin | 1.88 | -5.03 | -10.21 | - |
| EBITDA | - | - | - | - |
| Earnings Before Tax Margin | 1.84 | -3.08 | -11.91 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | -60 Thousand | -60 Thousand | -942 Thousand | -201 Thousand | -201 Thousand | -270 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | -60 Thousand | -60 Thousand | -942 Thousand | -201 Thousand | -201 Thousand | -270 Thousand |
| Operating Expenses | 157 Thousand | 157 Thousand | 791 Thousand | 197.5 Thousand | 197.5 Thousand | 198 Thousand |
| Selling, General and Administrative Expenses | 157 Thousand | 157 Thousand | - | 197.5 Thousand | 197.5 Thousand | 198 Thousand |
| Research and Development Expenses | - | - | - | 8 Million | 8 Million | - |
| Other Expenses | - | - | - | -8 Million | - | - |
| Cost and Expenses | 157 Thousand | 157 Thousand | 791 Thousand | 197.5 Thousand | 197.5 Thousand | 198 Thousand |
| Operating Income | -217 Thousand | -217 Thousand | -1.73 Million | -398.5 Thousand | -398.5 Thousand | -468 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | -37 Thousand | 21.5 Thousand | 21.5 Thousand | -148.25 Thousand |
| Earnings before Tax | -227.5 Thousand | -227.5 Thousand | -1.77 Million | -377 Thousand | -377 Thousand | -508 Thousand |
| Net Income | -227.5 Thousand | -227.5 Thousand | -1.77 Million | -377 Thousand | -377 Thousand | -508 Thousand |
| Earnings Per Share Basic | -0.06 | -0.06 | - | -0.09 | -0.09 | -0.12 |
| Earnings Per Share Diluted | -0.06 | -0.06 | - | -0.09 | -0.09 | -0.12 |
| Weighted Average Shares Outstanding | 4.13 Million | 4.13 Million | 4.02 Million | 3.98 Million | 3.98 Million | 4.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.13 Million | 4.13 Million | 4.02 Million | 3.98 Million | 3.98 Million | 4.06 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | - | -0.11 | -0.11 | 0.15 |
| Profit Margin | 3.79 | 3.79 | 1.88 | 1.88 | 1.88 | 1.88 |
| EBITDA | - | - | - | 21.5 Thousand | 21.5 Thousand | -40 Thousand |
| Earnings Before Tax Margin | 3.62 | 3.62 | 1.84 | 1.98 | 1.98 | 1.73 |
294870
SQX
300305
SVSO
8454
BTU